San Antonio, TX., November, 23, 2011 – Keraplast Technologies., the provider of Replicine Functional Keratin advanced wound care products, today announced it has signed a distribution agreement with Marathon Medical (Commerce City, CO) and applied to be added to Marathon Medical’s existing Federal Supply Schedule (FSS) contract, administered by the Department of Veterans Affairs (VA) on behalf of the U.S. General Services Administration (GSA).

The arrangement allows Keraplast Technologies to expand the availability of its advanced Replicine Functional Keratin advanced wound care products in partnership with Marathon Medical throughout the entire federal healthcare system, the largest healthcare provider in the United States with over 1,300 Veterans health facilities, Department of Defense medical treatment facilities, Military Hospitals, Indian Health Service Hospitals and other government agencies.

“We are very honored to have secured this contract, which not only offers a multitude of opportunities to give patients access to our life saving products, but ensures that veterans and active soldiers have access to our revolutionary technology” said Bill Moore, Chief Operating Officer. “Our partnership with Marathon Medical offers a breadth of coverage within the VA system, as they have both the necessary experience and expertise in government agency sales.”

Keraplast Technologies with it’s Keragel, Keramatrix, and Kerasorb product line is changing the approach to wound care with Bioactive Barrier support to patients. Its groundbreaking technology is introducing a new paradigm in management of acute and chronic wounds as well as burn patients, by accelerating the healing process.

“Marathon Medical with Keraplast Technologies affords us a great opportunity to benefit our ongoing commitment to honor all fellow U.S. military veterans and active military personnel,” said John St. Leger, president, Marathon Medical, a Service Disabled Veteran Owned Small Business and verified by the Center for Veterans Enterprise (CVE). “The Revolutionary products that Keraplast Technologies offers the VA and Department of Defense, facilitates a dramatically improved way of treating patients suffering from chronic wounds successfully, therefore avoiding more serious complications, or lengthy hospitalizations.”

Access to Replicine Functional Keratin advanced wound care technology is now well established across the US health care market. Keraplast CEO Michael Espensen added “Kerex LLC” is our DME supplier that gives public and private health providers direct access to Keraplast wound care technology, as well as private individuals in need of advanced wound care, such as families living with Epidermolysis Bullosa. Home health providers in the south west can access our technology through our partner Homesite Liveability. Adding Marathon Medical to our partners to give VA health facilities access to Replicine is a significant addition and builds on our solid foundation in the US wound care market.”

For more information contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it , visit www.keraplast.com or call 210 494 5596.

July 31st 2011.  Keraplast Technologies launched the first of many innovative beauty products containing Replicine^TM Functional Keratin^® at the world’s premier beauty event, Cosmoprof North America 2011.  The company’s ground breaking Hair Rescue product had salon professionals at the well-attended event boldly using the F-word as they sampled the product; “F” as in Functional Keratin.  

With a unique keratin protein that is 91% identical to hair keratin, the new back bar treatment has the right amino acids in the right place to deliver genuine hair repair inside the fibre. Offering:

•        80% less breakage

•        97% improvement in shine

•        83% boost in color symmetry

•        78% more natural looking color

Simply put, Replicine^TM can do what other keratins cannot.  

For more information on Hair Rescue with Replicine^TM Functional Keratin^® please contact:

Bill Moore

Chief Operating Officer

Keraplast Technologies, LLC

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Office: 210.494.5596

Fax: 210.490.6464

Mobile: 760.936.7932

Skype: WilliamDMoore11

www.keraplast.com

The introduction of a new paradigm in wound healing will continue at SAWC fall, Las Vegas October 13-15 2011.

Please come and visit Keraplast at booth 312 to learn more about Replicine^TM Functional Keratin^® advanced wound care technology and receive a complimentary DVD of the specialist Keratin Protein Advanced Wound Care symposium, held earlier this year.

The symposium entitled:

Keratin protein advanced wound care, a new paradigm in wound healing, held at SAWC, Dallas in April 2011, included specialist clinicians and scientific experts in the keratin field presenting the latest research and clinical findings on the emerging use of Replicine^TM Functional Keratin^® protein in wound care. An audience of wound care experts at the forefront of advanced care in the US heard the following series of talks:

Clinical Evaluation of Functional Keratin Wound Dressings

Robert S. Kirsner, MD, PhD, Professor, Vice Chairman & Stiefel Laboratories Chair, Department of Dermatology & Cutaneous Surgery, Chief of Dermatology University of Miami Miller School of Medicine

Keratin Formulations Promote Epithelialization in vitro and in vivo

Marjana Tomic-Canic, Ph.D, Research Professor, University of Miami Miller School of Medicine Department of Dermatology &Cutaneous Surgery

A Biodegradable Interface in Negative Pressure Wound Therapy

William Thompson, MD, Vascular surgeon, The Clinic of Mississippi, Jackson, Mississippi

Replicine^TM Functional Keratin^® Advanced Wound Dressings

Robert Kelly, Ph.D, Research Director, Keraplast Technologies, San Antonio, Texas.

Copies of the symposium are available on DVD. Please contact us  to receive your copy, or visit us in Las Vegas October 13-15 at SAWC fall.

As a result of the interest in this new paradigm in wound healing, Keraplast Technologies is working closely with a pioneering group of wound care professionals, introducing keratin advanced wound care technology in clinics across the US.

Exclusive salon styling products from internationally known Peter Coppola Haircare to Launch March 25 on Premium Interactive Retailer

Boca Raton, FL – March 22, 2011 – Peter Coppola Haircare announced today the premiere of its world-recognized brand on ShopNBC, a premium interactive retailer via TV, Internet and mobile. Peter Coppola’s internationally recognized brand debuts a line of salon styling products that create smooth, silky, voluminous hair instantly by eliminating frizz, curls and wavy unmanageable hair. The two-day premiere will debut on ShopNBC Friday, March 25 at 11am, 5pm & 9pm ET and Saturday, March 26 at 2am ET.

Peter Coppola is an internationally recognized stylist with over 40 years of experience in the professional hairstyling business and salon and styling product industry.  With over 30 salons worldwide, Peter has trained countless stylists and has been featured in numerous publications. He is revolutionizing the anti-aging hair care and straightening market with his innovative CopaGen Complex^TM hair care system.

Available exclusively on the ShopNBC network, Peter Coppola introduces the his CopaGen Complex^TM styling products, formulated with Keraplast Technologies, LLC (San Antonio, TX) Replicine™ brand Functional Keratin^® proteins.  The advanced proprietary keratin proteins utilized within the CopaGen Complex^TM mimic the hair’s natural structure, enabling absorption of the proteins to rescue, restore and protect hair from the inside out. Peter’s line of styling products create instantly smooth and silky hair at-home, without the cost of going to a salon.

Peter Coppola Haircare Favorites Include:

• Peter Coppola 4-Piece CopaGen Smoothing System (C53300)

Four-piece system includes pre-treatment, shampoo, conditioner and protein treatment. Designed to smooth hair in five minutes by elimating frizz, curl and wavy unmanageable hair. Formulated with no harsh chemicals or odor.

• Peter Coppola Mudd Texture Balm (C53301)

Defines, shapes, and directs styling with a non-sticky, non-greasy feel. Ultra light formula adds texture to hair for more manageable styling. 

• Peter Coppola Myst Hairspray Duo (C53303)

Self-adjusting nozzle offers three levels of hold – light, medium and firm. Formulated to add fullness, texture and lift with lasting hold

“The Replicine™ brand Functional Keratin® technology is the best protein ingredient I have ever seen in a hair care line.  The results are stunning.  This is the best formulation I have ever created and gives salon results at home,” said Peter.

 About Replicine™ brand Functional Keratin®.

 Replicine™ Functional Keratin® protein is closer in form and function to human hair keratin than any other material previously produced. Reversal of hair damage can only be achieved with Replicine brand Functional Technology that contains all of the essential components of the native protein.

Replicine Functional Keratin™ presents the hair with the exact building blocks needed for repair, rescue, renewal and protection in a form suitable to be delivered from a wide range of familiar hair care formulations.

• Rescue severely damaged hair through salon delivered treatments
• Repair and restore hair strength and condition through daily wash and care formulations
• Create more natural, even colors through pre-color keratin treatments
• Control frizz and style through keratin treatments and straightening systems

 For more information on Peter Coppola Haircare, please visit www.ShopNBC.com keyword: Peter Coppola.

Contacts

Keraplast Technologies proudly presents a specialist symposium at SAWC, Dallas, TX, April 14, 2011. Senior clinicians, across a broad spectrum of wound care fields, will share their experiences using Functional Keratin devices, including:

• Case study series of the treatment of venous leg ulcers;
• Case study series demonstrating substantial benefit using keratin products in the treatment of acute and chronic wounds arising from Epidermolysis Bullosa;
• Improvement of the wound-spacer interface when using keratin wound care products in combination with negative pressure wound therapy.

 In addition to experiences in the clinic, the use of keratin to accelerate the healing of acute wounds in standardized porcine models will be presented as well as the fundamental science of utilizing keratin protein in a way that maintains structure and function.

Speakers presenting at the symposium include:

Robert S. Kirsner, MD, PhD

Professor, Vice Chairman & Stiefel Laboratories Chair, Department of Dermatology & Cutaneous Surgery, Chief of Dermatology University of Miami Miller School of Medicine

Stephen C. Davis, Ph.D

Research Professor, University of Miami Miller School of Medicine Department of Dermatology &Cutaneous Surgery

William Thompson, MD

Vascular surgeon, The Clinic of Mississippi, Jackson, Mississippi

Robert Allen Smith, MD

Clinical Director, Keraplast Technologies, Plastic Surgeon, The Clinic of Mississippi, Jackson, Mississippi

Robert Kelly, Ph.D

Research Director, Keraplast Technologies, San Antonio, Texas

Keraplast will also be exhibiting their range of Functional Keratin wound care products at booth 1111 of the SAWC exhibition, April 14-17 2011, Gaylord Texan Hotel and Convention centre, Dallas, TX. Come visit us to learn more about the new paradigm in wound healing.

September 30th 2010, San Antonio TX, USA. Keraplast Technologies, a San Antonio based biotechnology company, announced today the issuing of two significant patents extending the global coverage of the company’s keratin protein technology. Continue reading →

July 30th 2010, San Antonio TX, USA. Keraplast Technologies, a San Antonio based biotechnology company, announced today expansion of its patent estate in the area of wound care. Continue reading →

May 10th 2010, San Antonio TX, USA. Keraplast Technologies, a San Antonio based biotechnology company, reported successful sponsorship and participation at the Dystrophic Epidermolysis Bullosa Research Association Patient Care conference in Cincinnati. Paul Rohricht, Chief Operating Officer for the company, described the involvement at the conference, “Keraplast has developed proprietary wound healing products, in particular the keratin rich gel Keragel, that have shown to offer significant quality of life improvements to families suffering from the severe skin disorder Epidermolysis Bullosa. Continue reading →

April 2010, San Antonio TX, USA. Keraplast Technologies, a San Antonio based biotechnology company presented findings of a case study series of venous leg ulcers. Continue reading →

July 2009, San Antonio TX, USA. Keraplast Technologies, a San Antonio based biotechnology company announced acquisition of New Zealand based Keratec Ltd. Continue reading →